儿童1级星形细胞瘤的监测影像:随访影像的时长与频率以及对比剂的使用能否减少?
该回顾性单中心研究纳入2007至2013年新诊断的非综合征性WHO 1级星形细胞瘤患儿88例,分析至2018年12月的690次监测扫描,发现31例因复发或进展而升级治疗,其中30例由监测影像发现;对比剂的使用在多数病例中未影响多学科团队决策,作者认为完全切除的小脑肿瘤可减少监测影像的次数和时长,且对比剂使用或可限制。
要点
- 88例患儿共690次监测扫描,31例复发或进展导致治疗升级,其中30例由监测影像识别。
- 对比剂的使用在多数病例中未对多学科团队的治疗升级决策产生贡献。
- 作者认为完全切除的小脑肿瘤可减少监测影像的次数和时长。
核心结论
- 完全切除的小脑肿瘤可减少监测影像的次数和时长。
- 多学科团队决策很少基于增强后影像,因此在儿童1级星形细胞瘤监测中对比剂使用或可限制。
研究设计与样本
- 回顾性单中心研究,于一家三级儿科医院开展。
- 纳入2007年至2013年间新诊断的非综合征性WHO 1级星形细胞瘤患儿,分析截至2018年12月的监测影像。
- 共88例患者,690次监测扫描;记录监测影像间隔,并查阅影像和电子健康记录以确定治疗升级决策。
关键影像表现/征象
- 31例患者出现复发或进展导致治疗升级,其中30例由监测影像识别。
临床应用与阅片要点
- 作者认为完全切除的小脑肿瘤可减少监测影像的次数和时长。
- 作者认为多学科团队决策很少基于增强后影像,对比剂使用或可限制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The optimum strategy for the surveillance of low-grade gliomas in children has not been established, and there is concern about the use of gadolinium-based contrast agents (GBCAs), particularly in children, due to their deposition in the brain. The number of surveillance scans and the use of GBCAs in surveillance of low-risk tumours should ideally be limited. We aimed to investigate the consistency and utility of our surveillance imaging and also determine to what extent the use of GBCAs contributed to decisions to escalate treatment in children with grade 1 astrocytomas.
METHODS: This was a retrospective single-centre study at a tertiary paediatric hospital. All children with a new diagnosis of a non-syndromic World Health Organization (WHO) grade 1 astrocytoma between 2007 and 2013 were included, with surveillance imaging up to December 2018 included in analysis. The intervals of surveillance imaging were recorded, and imaging and electronic health records were examined for decisions related to treatment escalation.
RESULTS: Eighty-eight patients had 690 surveillance scans in the study period. Thirty-one patients had recurrence or progression leading to treatment escalation, 30 of whom were identified on surveillance imaging. The use of GBCAs did not appear to contribute to multidisciplinary team (MDT) decisions in the majority of cases.
CONCLUSION: Surveillance imaging could be reduced in number and duration for completely resected cerebellar tumours. MDT decisions were rarely made on the basis of post-contrast imaging, and GBCA administration could therefore potentially be restricted in the setting of surveillance of grade 1 astrocytomas in children.
引用
- Campion T, Quirk B, Cooper J, et al. Surveillance imaging of grade 1 astrocytomas in children: can duration and frequency of follow-up imaging and the use of contrast agents be reduced? Neuroradiology. 2020. PMID: 33241451. doi:10.1007/s00234-020-02609-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。